Literature DB >> 20883266

Acrodermatitis enteropathica: a review of 29 Tunisian cases.

Monia Kharfi1, Nadia El Fékih, Hajer Aounallah-Skhiri, Sébastien Schmitt, Bécima Fazaa, Sébastien Küry, Mohamed Ridha Kamoun.   

Abstract

INTRODUCTION: Acrodermatitis enteropathica is a rare autosomal recessive disease due to an abnormality in a zinc transporting molecule.
METHODS: We conducted a retrospective monocentric study on 29 Tunisian cases of Acrodermatitis enteropathica (AE) treated in our Department of Dermatology in Tunisia, between January 1981 and June 2008.
RESULTS: The age of onset of disorders was between 15 d and 12 months (mean 6.86 ± 3.25 months). The delay of consultation ranged between 15 d and 8 months (mean of 2.8 ± 2.17 months) after onset. Onset of gastrointestinal and psychiatric signs depended significantly on consulting times. Plasma zinc levels ranged between 14 and 88 lg/100 ml (mean 44.86 ± 18.4 lg/100 ml). There was not a significant relation between zincemia and clinical features. Genetic analyses in 13 of our patients showed three different mutations in the SLC39A4 gene: c.1223_1227del (p.Trp411ArgfsX7) in exon 7,c.143T>G (p.Leu48X) in exon 1 and c.1784T>C (p.Gly595Val) in exon 11. No significant genotype-phenotype correlations could be established.
CONCLUSION: Acrodermatitis enteropathica is a rare disease which diagnosis is easy. Its biological confirmation is made on a simple dosage of zincemia. However, the diagnosis is not always suggested, and is unfortunately made late. At present, there is a molecular test to detect SLC39A4 mutations.
© 2010 The International Society of Dermatology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20883266     DOI: 10.1111/j.1365-4632.2010.04566.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  6 in total

1.  Clinical utility gene card for: acrodermatitis enteropathica.

Authors:  Sébastien Küry; Monia Kharfi; Sébastien Schmitt; Stéphane Bézieau
Journal:  Eur J Hum Genet       Date:  2011-12-14       Impact factor: 4.246

2.  Clinical utility gene card for: acrodermatitis enteropathica - update 2015.

Authors:  Sébastien Küry; Monia Kharfi; Eric Blouin; Sébastien Schmitt; Stéphane Bézieau
Journal:  Eur J Hum Genet       Date:  2015-10-07       Impact factor: 4.246

3.  Heterogeneity in the genetic alterations and in the clinical presentation of acrodermatitis enteropathic: Case report and review of the literature.

Authors:  G Ricci; S Ferrari; E Calamelli; L Ricci; I Neri; A Patrizi
Journal:  Int J Immunopathol Pharmacol       Date:  2015-12-18       Impact factor: 3.219

4.  A Zinc Sulphate-Resistant Acrodermatitis Enteropathica Patient with a Novel Mutation in SLC39A4 Gene.

Authors:  M Kilic; M Taskesen; T Coskun; F Gürakan; A Tokatli; H S Sivri; A Dursun; S Schmitt; S Küry
Journal:  JIMD Rep       Date:  2011-09-06

5.  Founder mutations in Tunisia: implications for diagnosis in North Africa and Middle East.

Authors:  Lilia Romdhane; Rym Kefi; Hela Azaiez; Nizar Ben Halim; Koussay Dellagi; Sonia Abdelhak
Journal:  Orphanet J Rare Dis       Date:  2012-08-21       Impact factor: 4.123

6.  Acquired zinc deficiency in an adult female.

Authors:  Mohanan Saritha; Divya Gupta; Laxmisha Chandrashekar; Devinder M Thappa; Nachiappa G Rajesh
Journal:  Indian J Dermatol       Date:  2012-11       Impact factor: 1.494

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.